PI-LAB-2026-198

Pemvidutide, Independent Lab Report

Pemvidutide 1.8mg · Northwind Telehealth

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 96.5% met the stated ≥98% claim. Content measured 100.0% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
96.5%

Label claimed ≥98%

Content accuracy
100%

1.8mg measured against 1.8mg claimed

Test recency
Current cycle

Published 7 months ago

Specimen PI-LAB-2026-198 Tested by Axiom Mass Spec Services 8 samples tested from this company Purity & Testing score 81/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 96.5% Within analytical tolerance
Identity (MS) Pemvidutide Confirmed Matches label
Content 1.8 mg 1.8 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
A3099-26
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Purity & identity

Original laboratory report: PI-LAB-2026-198-report.pdf (document delivery arrives with the production storage backend)

More Tests, Northwind Telehealth

Amycretin
Purity 97.5% Verified
Tirzepatide (Compounded)
Purity 97.4% Verified
Tirzepatide
Purity 97.4% Verified

More Tests, Pemvidutide

Pemvidutide Apex Peptides
Purity 94.5% Verified
Pemvidutide Quantum Peptide Group
Purity 97.7% Verified